In March 2020, the FDA granted emergency use authorization (EUA) for Hydroxychloroquine but they revoked the EUA for HCQ a few months later on June 15, 2020 after determining that the "legal criteria for issuing an EUA were no longer met".
In March 2020, the FDA granted emergency use authorization (EUA) for Hydroxychloroquine but they revoked the EUA for HCQ a few months later on June 15, 2020 after determining that the "legal criteria for issuing an EUA were no longer met".